Terms: = Leukemia AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776
54 results:
1. Long-term surveillance of the feline leukemia virus in the endangered Iberian lynx (Lynx pardinus) in Andalusia, Spain (2008-2021).
Nájera F; López G; Del Rey-Wamba T; Malik RA; Garrote G; López-Parra M; Fernández-Pena L; García-Tardío M; Arenas-Rojas R; Simón MA; Zorrilla I; Fernández I; Alcaide EM; Ruiz C; Revuelta L; Salcedo J; Hofmann-Lehmann R; Meli ML
Sci Rep; 2024 Mar; 14(1):5462. PubMed ID: 38443503
[TBL] [Abstract] [Full Text] [Related]
2. Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study.
Olszewski AJ; Phillips TJ; Hoffmann MS; Armand P; Kim TM; Yoon DH; Mehta A; Greil R; Westin J; Lossos IS; Munoz JL; Sit J; Wei MC; Yang A; Chen V; Purev E; Yee DL; Jaeger U
Blood Adv; 2023 Oct; 7(20):6055-6065. PubMed ID: 37581593
[TBL] [Abstract] [Full Text] [Related]
3. Impact of a novel prognostic model on allogeneic hematopoietic stem cell transplantation outcomes in patients with CMML.
Zhou JY; Wang S; Yuan HL; Xu YJ; Huang XB; Gao SJ; Zhang YC; Zhou F; Liu Y; Song XM; Cai Y; Liu XL; Luo Y; Yang LX; Yang JM; Wang LB; Li YH; Huang R; Wang SQ; Zhou M; Dong YJ; Wang Q; Zhang X; Feng YM; Du X; Ling W; Zhu H; Zhu ZM; Chen XL; Wang SY; Meng FK; Bi KH; Huang N; Jiang M; Niu T; Ji J; Wan DM; Bian ZL; Chen Y; Liu L; Yan XQ; Yang X; Yi H; Wei XD; Li X; Cheng Q; Yuan CL; Wang W; Zhou YH; Ye BD; Ding J; Wu YJ; Huang QS; Zhu XL; Chen YH; He Y; Wang FR; Zhang YY; Mo XD; Han W; Wang JZ; Wang Y; Chen H; Zhao XY; Chang YJ; Liu KY; Huang XJ; Zhang XH
Am J Hematol; 2023 Sep; 98(9):1394-1406. PubMed ID: 37366294
[TBL] [Abstract] [Full Text] [Related]
4. [Incidence and clinical characteristics of engraftment syndrome after syngeneic hematopoietic stem cell transplantation in patients with hematological diseases].
Lou R; Xu LP; Zhang XH; Liu KY; Wang Y; Yan CH; Huang XJ; Sun YQ
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):289-294. PubMed ID: 37356997
[No Abstract] [Full Text] [Related]
5. Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models.
Singh D; Gupta M; Sarwat M; Siddique HR
Crit Rev Oncol Hematol; 2022 Aug; 176():103751. PubMed ID: 35752426
[TBL] [Abstract] [Full Text] [Related]
6. The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan.
Huang HH; Chen CM; Wang CY; Hsu WW; Chen HM; Ko BS; Hsiao FY
PLoS One; 2022; 17(1):e0261871. PubMed ID: 35061709
[TBL] [Abstract] [Full Text] [Related]
7. Risk of mortality and second malignancies in primary myelofibrosis before and after ruxolitinib approval.
Thomas JW; Jamy O; Shah MV; Vachhani P; Go RS; Goyal G
Leuk Res; 2022 Jan; 112():106770. PubMed ID: 34920340
[TBL] [Abstract] [Full Text] [Related]
8. Pharmacokinetics of Asciminib When Taken With Imatinib or With Food.
Hoch M; Zack J; Quinlan M; Huth F; Forte S; Dodd S; Aimone P; Hourcade-Potelleret F
Clin Pharmacol Drug Dev; 2022 Feb; 11(2):207-219. PubMed ID: 34609077
[TBL] [Abstract] [Full Text] [Related]
9. Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML.
Niederwieser C; Morozova E; Zubarovskaya L; Zabelina T; Klyuchnikov E; Janson D; Wolschke C; Christopeit M; Ayuk F; Moiseev I; Afanasyev BV; Kröger N
Bone Marrow Transplant; 2021 Nov; 56(11):2834-2841. PubMed ID: 34331022
[TBL] [Abstract] [Full Text] [Related]
10. Pharmacological mechanism of mylabris in the treatment of leukemia based on bioinformatics and systematic pharmacology.
Zhan H; Bai Y; Lv Y; Zhang X; Zhang L; Deng S
Bioengineered; 2021 Dec; 12(1):3229-3239. PubMed ID: 34224300
[TBL] [Abstract] [Full Text] [Related]
11. Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
Solana-Altabella A; Boluda B; Rodríguez-Veiga R; Cano I; Acuña-Cruz E; Blanco A; Marco-Ayala J; de la Puerta R; Díaz-González Á; Piñana JL; Sanz J; Sempere A; Cervera J; Barragán E; Sargas C; Ballesta-López O; Megías-Vericat JE; Martínez-Cuadrón D; Sanz MÁ; Montesinos P
Eur J Haematol; 2021 May; 106(5):724-733. PubMed ID: 33609315
[TBL] [Abstract] [Full Text] [Related]
12. Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.
Pleyer C; Ali MA; Cohen JI; Tian X; Soto S; Ahn IE; Gaglione EM; Nierman P; Marti GE; Hesdorffer C; Lotter J; Superata J; Wiestner A; Sun C
Blood; 2021 Jan; 137(2):185-189. PubMed ID: 33259596
[TBL] [Abstract] [Full Text] [Related]
13. Differences in diagnosis, treatment, and survival rate of acute myeloid leukemia with or without disabilities: A national cohort study in the Republic of Korea.
Kwon J; Kim SY; Yeob KE; Han HS; Lee KH; Shin DW; Kim YY; Park JH; Park JH; Kawachi I
Cancer Med; 2020 Aug; 9(15):5335-5344. PubMed ID: 32491262
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid leukemia.
Bai Z; Yao Q; Sun Z; Xu F; Zhou J
Technol Cancer Res Treat; 2019 Jan; 18():1533033819873927. PubMed ID: 31522654
[TBL] [Abstract] [Full Text] [Related]
15. Center effect in intubation risk in critically ill immunocompromised patients with acute hypoxemic respiratory failure.
Dumas G; Demoule A; Mokart D; Lemiale V; Nseir S; Argaud L; Pène F; Kontar L; Bruneel F; Klouche K; Barbier F; Reignier J; Stoclin A; Louis G; Constantin JM; Wallet F; Kouatchet A; Peigne V; Perez P; Girault C; Jaber S; Cohen Y; Nyunga M; Terzi N; Bouadma L; Lebert C; Lautrette A; Bigé N; Raphalen JH; Papazian L; Benoit D; Darmon M; Chevret S; Azoulay E
Crit Care; 2019 Sep; 23(1):306. PubMed ID: 31492179
[TBL] [Abstract] [Full Text] [Related]
16. The impact of chronic myeloid leukemia on employment: the French prospective study.
De Barros S; Vayr F; Despas F; Strumia M; Podevin C; Gauthier M; Delabesse E; Soulat JM; Laurent G; Huguet F; Herin F
Ann Hematol; 2019 Mar; 98(3):615-623. PubMed ID: 30446803
[TBL] [Abstract] [Full Text] [Related]
17. Differences in incidence and survival to childhood cancer between rural and urban areas in Castilla y León, Spain (2003-2014): A Strobe-compliant study.
González García H; Garrote Molpeceres R; Urbaneja Rodríguez E; Gutiérrez Meléndez P; Herráiz Cristóbal R; Pino Vázquez MA
Medicine (Baltimore); 2018 Oct; 97(41):e12797. PubMed ID: 30313108
[TBL] [Abstract] [Full Text] [Related]
18. Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia: clinical characteristics, incidence, risk factors and outcomes.
Alhashim N; Aljurf M; Hassanein M; Chaudhri N; Hashmi S; El-Gohary G; Alsharif F; Alsermani M; Alhumaid M; Beihany AA; Shaheen M; Hanbali A; Alfraih F; Mohamed S; Alzahrani H; Elhassan T; Eldali A; Rasheed W; Ahmed S; Almohareb F; El Fakih R
Bone Marrow Transplant; 2018 Jul; 53(7):838-843. PubMed ID: 29371685
[TBL] [Abstract] [Full Text] [Related]
19. Sepsis and Acute Myeloid leukemia: A Population-Level Study of Comparative Outcomes of Patients Discharged From Texas Hospitals.
Malik IA; Cardenas-Turanzas M; Gaeta S; Borthakur G; Price K; Cortes J; Nates JL
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e27-e32. PubMed ID: 28844403
[TBL] [Abstract] [Full Text] [Related]
20. Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.
Valent P; Akin C; Hartmann K; Nilsson G; Reiter A; Hermine O; Sotlar K; Sperr WR; Escribano L; George TI; Kluin-Nelemans HC; Ustun C; Triggiani M; Brockow K; Gotlib J; Orfao A; Schwartz LB; Broesby-Olsen S; Bindslev-Jensen C; Kovanen PT; Galli SJ; Austen KF; Arber DA; Horny HP; Arock M; Metcalfe DD
Cancer Res; 2017 Mar; 77(6):1261-1270. PubMed ID: 28254862
[TBL] [Abstract] [Full Text] [Related]
[Next]
